Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Ibuprofen D vs Nurofen for Children in Healthy Volunteers
NCT03561558Phase 1Completed
- Sponsor
- Pharmtechnology
- Start
- Jun 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ibuprofen in pain, fever and inflammation (2 arms), sponsored by Pharmtechnology. Primary endpoints: Maximum Plasma Concentration for S-enantiomer of ibuprofen at 8 days and Area Under the Curve from time 0 to last measurable concentration for S-enantiomer of ibuprofen at 8 days. Started Jun 2018; status: completed.
02
Drugs
ibuprofen
03
Conditions
painfeverinflammation
Beyond the preview
Go deeper on NCT03561558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03561558.